NCT04266665 Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome Status COMPLETED Phase PHASE4
NCT04233788 Metabolic Characterization of Space Occupying Lesions of the Brain Status RECRUITING Phase N/A
NCT04209023 The Use of Navigated Transcranial Magnetic Stimulation (nTMS) in the Inhibition of Neurofunctional Regions of Interest Status SUSPENDED Phase NA
NCT04200066 A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma Status WITHDRAWN Phase PHASE1
NCT04178057 Phase I Clinical Study of GB222 to Evaluate the Safety, Tolerability and PK Profiles. Status UNKNOWN Phase PHASE1
NCT04101123 Children and Adolescents With Leukemia, Brain Tumors, and Sarcomas Status COMPLETED Phase N/A
NCT04085887 Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures Status RECRUITING Phase PHASE1/PHASE2
NCT04075305 The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study Status RECRUITING Phase N/A
NCT04074785 Abemaciclib w/Bevacizumab in Recurrent GBM Pts w/Loss of CDKN2A/B or Gain or Amplification of CDK4/6 Status TERMINATED Phase EARLY_PHASE1
NCT04069910 Stereotactic Radiation Therapy Before Surgery for the Treatment of Resectable Brain Metastases Status WITHDRAWN Phase NA
NCT04055688 Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas Status COMPLETED Phase N/A
NCT04047602 Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study Status TERMINATED Phase NA
NCT04033497 Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases Status RECRUITING Phase NA
NCT04028479 The Registry of Oncology Outcomes Associated with Testing and Treatment Status COMPLETED Phase N/A
NCT04023669 Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors Status COMPLETED Phase PHASE1